Private Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-11,100
| Closed | -$210K | – | 137 |
|
2017
Q4 | $210K | Sell |
11,100
-21,375
| -66% | -$404K | 0.03% | 133 |
|
2017
Q3 | $572K | Sell |
32,475
-144,545
| -82% | -$2.55M | 0.09% | 94 |
|
2017
Q2 | $5.88M | Buy |
177,020
+53,945
| +44% | +$1.79M | 0.95% | 40 |
|
2017
Q1 | $3.95M | Buy |
123,075
+9,727
| +9% | +$312K | 0.64% | 46 |
|
2016
Q4 | $4.11M | Buy |
113,348
+2,090
| +2% | +$75.8K | 0.69% | 46 |
|
2016
Q3 | $5.12M | Buy |
111,258
+670
| +0.6% | +$30.8K | 0.86% | 39 |
|
2016
Q2 | $5.56M | Buy |
110,588
+40,850
| +59% | +$2.05M | 0.98% | 37 |
|
2016
Q1 | $3.73M | Sell |
69,738
-4,050
| -5% | -$217K | 0.68% | 47 |
|
2015
Q4 | $4.84M | Sell |
73,788
-5,425
| -7% | -$356K | 0.88% | 38 |
|
2015
Q3 | $4.47M | Sell |
79,213
-61,045
| -44% | -$3.45M | 0.84% | 38 |
|
2015
Q2 | $8.29M | Sell |
140,258
-31,300
| -18% | -$1.85M | 1.39% | 24 |
|
2015
Q1 | $10.7M | Sell |
171,558
-4,585
| -3% | -$286K | 1.74% | 19 |
|
2014
Q4 | $10.1M | Sell |
176,143
-3,719
| -2% | -$214K | 1.61% | 22 |
|
2014
Q3 | $9.67M | Sell |
179,862
-1,452
| -0.8% | -$78K | 1.55% | 21 |
|
2014
Q2 | $9.5M | Sell |
181,314
-11,448
| -6% | -$600K | 1.53% | 21 |
|
2014
Q1 | $10.2M | Sell |
192,762
-395
| -0.2% | -$20.9K | 1.72% | 16 |
|
2013
Q4 | $7.74M | Buy |
193,157
+15,895
| +9% | +$637K | 1.33% | 25 |
|
2013
Q3 | $6.7M | Sell |
177,262
-40,767
| -19% | -$1.54M | 1.28% | 26 |
|
2013
Q2 | $8.55M | Buy |
+218,029
| New | +$8.55M | 1.63% | 17 |
|